LivaNova PLC (LIVN)

NASDAQ: LIVN · USD

$80.5

+0.14 (+0.2%)· Recorded snapshot

Market cap	4.4B
Revenue (ttm)	1.5B
Net income (ttm)	188.6M
EPS (ttm)	$3.40
Shares out	55.1M
P/E (trailing)	23.7x
P/E (forward)	18.0x
Volume	389,209
Beta	0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5B
Net income (ttm): 188.6M
EPS (ttm): $3.40
P/E (trailing): 23.7x
P/E (forward): 18.0x
Market cap: 4.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18

P25 n/aP50 n/aP75 n/a

Trailing P/E23.7

P25 n/aP50 n/aP75 n/a

ROE15.4

P25 n/aP50 n/aP75 n/a

ROIC19.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LIVN indicators

Market & fundamental data

Available fields

262

Groups with data

Currency

USD

Showing 262 of 262 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001639691
Company name	LivaNova PLC
Country	United Kingdom
Country code	US
CUSIP number	G5509L101
Earnings date	2026-11-04
Earnings time	bmo
Employees	3,300
Employees change	400
Employees growth	13.79%
Enterprise value	$4.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
In index	RUSSELL2000
Industry	Medical Devices
IPO date	1993-02-10
Is primary listing	Yes
Is SPAC	No
ISIN number	GB00BYMT0J19
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$4.4B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$80.52
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	LIVN
Website	https://www.livanova.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	19.13x
Earnings yield	4.22%
EV/Earnings	22.77x
EV/EBIT	20.69x
EV/EBITDA	16.51x
EV/FCF	28.95x
EV/Sales	2.92x
FCF / EV yield	3.45%
FCF yield	3.33%
Forward EV/Sales	2.73x
Forward P/E	17.95x
Forward P/S	2.83x
Graham number	42.92679
Graham upside	-46.96%
Industry forward P/E	19.74x
Industry P/E	39.16x
P/(FCF - SBC) ratio	42.95x
P/(OCF - SBC) ratio	21.77x
P/B ratio	3.34x
P/E ratio	23.67x
P/FCF ratio	30.06x
P/OCF ratio	17.89x
P/S ratio	3.03x
Price / tangible book value	13.55x
Price/EBITDA ratio	17.14x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.1%
EBITDA margin	17.68%
FCF margin	10.08%
Gross margin	67.74%
Operating margin	14.1%
Pretax margin	7.24%
Profit margin	12.81%
Profit per employee	$57,137
Profitable quarters	5
Revenue per employee	$445,915
ROA	5.04%
ROA (5Y)	2.96%
ROCE	10.73%
ROE	15.4%
ROE (5Y)	-6.23%
ROIC	19.08%
ROIC (5Y)	7.4%
SBC / revenue	3.02%
Tax / revenue	-5.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	287.81%
EPS growth (QoQ)	382.5%
EPS growth 10Y	20.22%
EPS growth quarters	2
EPS growth years	0
FCF growth	-8.51%
FCF growth (Q)	-26.66%
FCF growth (QoQ)	3,683.8%
FCF growth 3Y	73%
FCF growth 5Y	20.22%
Gross profit growth	11.54%
Gross profit growth (Q)	10.18%
Gross profit growth 3Y	11.29%
Gross profit growth 5Y	9.46%
Net income growth (Q)	299.72%
Net income growth (QoQ)	386.99%
Net income growth quarters	2
Net income growth years	0
OCF growth	15.08%
OCF growth (Q)	5.83%
OCF growth (QoQ)	337.62%
OCF growth 10Y	11.16%
OCF growth 3Y	63.37%
OCF growth 5Y	22.39%
Operating income growth	-0.61%
Operating income growth (Q)	-7.01%
Operating income growth 3Y	87.53%
Revenue growth	12.39%
Revenue growth (Q)	10.8%
Revenue growth (QoQ)	7.82%
Revenue growth 10Y	17.45%
Revenue growth 3Y	10.7%
Revenue growth 5Y	7.57%
Revenue growth quarters	15
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-101M
Depreciation and amortization	$52.6M
EBIT	$207.5M
EBITDA	$260.1M
EPS	$3.40
FCF per share	$2.69
Financing cash flow	$-223M
Free cash flow	$148.3M
Free cash flow minus SBC	$103.8M
Gross profit	$996.8M
Income taxes	$-82M
Investing cash flow	$-99.8M
Net borrowing	$-166.6M
Net cash flow	$-77M
Net income	$188.6M
Operating cash flow minus SBC	$204.8M
Operating income	$207.5M
Revenue	$1.5B
Stock-based compensation	$44.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.93
Book value per share	$24.07
Debt / EBITDA	1.28
Debt / equity	0.27
Debt / FCF	2.37
Goodwill	$779.1M
Interest coverage	6.01
Long-term assets	$1.6B
Long-term liabilities	$608.5M
Net cash (debt)	$164.7M
Net cash / market cap	3.69%
Net cash growth	48.54%
Net debt / EBITDA	-0.63
Net debt / equity	-0.12
Net debt / FCF	-1.11
Piotroski F-Score	7
Property, plant and equipment	$330M
Shareholders' equity	$1.3B
Tangible book value	$329.2M
Tangible book value per share	$5.98
Total assets	$2.6B
Total cash	$516.6M
Total debt	$351.9M
Total liabilities	$1.3B
WACC	8.97%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	$1B
Current liabilities	$707M
Current ratio	1.45
Inventory turnover	2.81
Net working capital	$-186.2M
Quick ratio	1.08
Working capital	$318M
Working capital turnover	5.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.77%
Dividend yield	0%
Shareholder yield	-1.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	41.89%
10Y return CAGR	3.56%
10Y total return	41.89%
150-day SMA	$75.35
15Y price change	171.59%
15Y return CAGR	6.89%
15Y total return	171.59%
1D price change	0.17%
1M price change	5.16%
1M total return	5.16%
1W price change	1.09%
1W total return	1.09%
1Y price change	48.45%
1Y return CAGR	48.49%
1Y total return	48.45%
20-day SMA	$77.76
200-day SMA	$72.71
20Y price change	349.41%
20Y return CAGR	7.8%
20Y total return	349.41%
3Y price change	70.76%
3Y return CAGR	19.52%
3Y total return	70.76%
50-day SMA	$78.47
50-day SMA vs 200-day SMA	50over200
52-week high	$85.76
52-week high date	2026-08-04
52-week low	$48.82
52-week low date	2025-11-06
5Y price change	2.85%
5Y return CAGR	0.56%
5Y total return	2.85%
6M price change	27.08%
6M total return	27.08%
All-time high	$131.54
All-time high date	2018-09-12
All-time low	$1.88
All-time low date	1994-10-18
Average true range (ATR)	$2.12
Average volume	548.5K
Beta (1Y)	1.2
Beta (2Y)	0.88
Beta (5Y)	0.88
Change from 52-week high	-6.11%
Change from 52-week low	64.93%
Change from all-time high	-38.74%
Change from all-time low	4,197.6%
Change from open	0.25%
Day's gap	-0.07%
Dollar volume	$31.3M
High price	$81.71
Low price	$80.24
Monthly RSI	63.6
Open price	$80.32
Position in 52-week range	19.05%
Premarket change	0.29%
Premarket close	$80.38
Premarket price	$80.61
Premarket volume	2.8K
Previous close	$80.38
Price vs 150-day SMA	6.94%
Price vs 20-day SMA	3.63%
Price vs 200-day SMA	10.83%
Price vs 50-day SMA	2.69%
Relative volume	0.71
RSI	58.6
Sharpe ratio	1.16
Sharpe ratio (3Y)	0.53
Sharpe ratio (5Y)	0.09
Sortino ratio	2.16
Sortino ratio (3Y)	1.02
Sortino ratio (5Y)	0.29
Volume	389.2K
Weekly RSI	58.37
YTD price change	30.96%
YTD total return	30.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54.8M
Float percentage	99.53%
Shares change (QoQ)	0.58%
Shares change (YoY)	1.77%
Shares held by insiders	0.44%
Shares held by institutions	113.63%
Shares outstanding	55.1M
Short % of float	11.31%
Short % of shares	11.25%
Short ratio	9.1 days

Deeper analysis on LIVN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LIVN report

Is a complete LIVN research report available?

No complete published report is available for LivaNova PLC (LIVN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LivaNova PLC (LIVN)

Price

Financial snapshot

Fair-value bridge

Latest news · LIVN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LIVN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LIVN

Frequently asked questions